跳至主要内容
临床试验/NCT04338776
NCT04338776进行中(未招募)不适用

C.L.E.A.R. - Comparing UroLift Experience Against Rezūm

NeoTract, Inc.20 个研究点 分布在 2 个国家目标入组 120 人开始时间: 2021年1月22日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
120
试验地点
20
主要终点
Catheter Independent

研究概览

简要总结

C.L.E.A.R. Study is poised to compare the patient experience post procedure, including catheterization needs as well as retreatment and BPH medication rates following treatment with either the UroLift® System or Rezūm™ System through 12 months.

详细描述

Patients will be randomized to either the UroLift or Rezum arm. Post-procedure, subjects who receive a catheter between post-procedure and prior to discharge, will return to office to complete a voiding assessment.

All subjects will be expected to complete questionnaires and assessments, as part of SOC (varies by institution), at day 3, day 7, 2 weeks, 1 month, 3 months and 12 months post-procedure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Male gender
  • Age ≥ 50 years
  • Diagnosis of symptomatic BPH
  • Prostate volume 30cm3 ≤ 80cm3
  • Willing to sign study informed consent form

排除标准

  • Current urinary tract infection
  • Current catheter dependent urinary retention or PVR >= 500 mL
  • Urethra conditions that may prevent insertion of delivery system into bladder
  • Previous BPH surgical procedure
  • Urinary incontinence presumed due to incompetent sphincter
  • Current gross hematuria
  • Patients with a urinary sphincter implant
  • Patients who have a penile prosthesis
  • Currently enrolled in any other investigational clinical research trial that has not completed the primary endpoint

结局指标

主要结局

Catheter Independent

时间窗: Through 1-week

Number of subjects who are catheter independent and remain catheter independent through 1-week

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验